top of page
![](https://static.wixstatic.com/media/ec2135_d479194f1a674a11a09141ac174a83cc.jpg/v1/fill/w_322,h_55,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/ec2135_d479194f1a674a11a09141ac174a83cc.jpg)
![](https://static.wixstatic.com/media/ec2135_4632cf06dd8d43aab21c142588334912.png/v1/fill/w_68,h_65,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/ec2135_4632cf06dd8d43aab21c142588334912.png)
MARKET-OVERVIEW
OVERVIEW
Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.
Market Strategy
Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.
-
Lower cost
-
User convenience
-
Value of information
-
Facilitation of doctor-patient feedback
-
Therapeutic intervention
bottom of page